• Citer

Oxaliplatin or paclitaxel in patients with platinum-pretreated advanced ovarian cancer: A randomized phase II study of the European Organization for Research and Treatment of Cancer Gynecology Group.

par Piccart-Gebhart, Martine ;Green, J A;Lacave, Ángel Jiménez;Reed, N;Vergote, Ignace;Benedetti-Panici, P;Bonetti, A;Kristeller-Tome, V;Fernandez, C M;Curran, D.;van Glabbeke, Martine;Lacombe, Denis;Pinel, M C;Pecorelli, Sërgio
Référence Journal of clinical oncology, 18, 6, page (1193-1202)
Publication Publié, 2000-03

Article révisé par les pairs

• Détails
• Contenu

Titre:	Oxaliplatin or paclitaxel in patients with platinum-pretreated advanced ovarian cancer: A randomized phase II study of the European Organization for Research and Treatment of Cancer Gynecology Group.
Auteur:	Piccart-Gebhart, Martine; Green, J A; Lacave, Ángel Jiménez; Reed, N; Vergote, Ignace; Benedetti-Panici, P; Bonetti, A; Kristeller-Tome, V; Fernandez, C M; Curran, D.; van Glabbeke, Martine; Lacombe, Denis; Pinel, M C; Pecorelli, Sërgio
Informations sur la publication:	Journal of clinical oncology, 18, 6, page (1193-1202)
Statut de publication:	Publié, 2000-03
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Adult
	Aged
	Aged, 80 and over
	Antineoplastic Agents -- therapeutic use
	Carboplatin -- therapeutic use
	Cisplatin -- therapeutic use
	Female
	Humans
	Middle Aged
	Organoplatinum Compounds -- therapeutic use
	Ovarian Neoplasms -- drug therapy
	Paclitaxel -- therapeutic use
	Quality of Life
	Survival Analysis
Note générale:	Clinical Trial
	Clinical Trial, Phase II
	Journal Article
	Multicenter Study
	Randomized Controlled Trial
	Research Support, Non-U.S. Gov't
Langue:	Anglais
Identificateurs:	urn:issn:0732-183X
	info:pmid/10715288